000 01788 a2200517 4500
005 20250516230315.0
264 0 _c20141111
008 201411s 0 0 eng d
022 _a1090-2104
024 7 _a10.1016/j.bbrc.2014.08.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aXu, Ya-Qiong
245 0 0 _aAloperine attenuated neuropathic pain induced by chronic constriction injury via anti-oxidation activity and suppression of the nuclear factor kappa B pathway.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cSep 2014
300 _a568-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aConstriction
650 0 4 _aDown-Regulation
650 0 4 _aHot Temperature
650 0 4 _aHyperalgesia
_xdrug therapy
650 0 4 _aInterleukin-1beta
_xbiosynthesis
650 0 4 _aInterleukin-6
_xbiosynthesis
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aNF-kappa B
_xantagonists & inhibitors
650 0 4 _aNeuralgia
_xdrug therapy
650 0 4 _aPiperidines
_xpharmacology
650 0 4 _aQuinolizidines
650 0 4 _aSciatic Nerve
_xinjuries
650 0 4 _aTumor Necrosis Factor-alpha
_xbiosynthesis
700 1 _aJin, Shao-Ju
700 1 _aLiu, Ning
700 1 _aLi, Yu-Xiang
700 1 _aZheng, Jie
700 1 _aMa, Lin
700 1 _aDu, Juan
700 1 _aZhou, Ru
700 1 _aZhao, Cheng-Jun
700 1 _aNiu, Yang
700 1 _aSun, Tao
700 1 _aYu, Jian-Qiang
773 0 _tBiochemical and biophysical research communications
_gvol. 451
_gno. 4
_gp. 568-73
856 4 0 _uhttps://doi.org/10.1016/j.bbrc.2014.08.025
_zAvailable from publisher's website
999 _c24102874
_d24102874